<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.0//EN" "ep-patent-document-v1-0.dtd">
<ep-patent-document id="EP00116623B9W1" file="00116623.xml" lang="en" country="EP" doc-number="1074626" kind="B9" correction-code="W1" date-publ="20060719" status="c" dtd-version="ep-patent-document-v1-0">
<SDOBI lang="en"><B000><eptags><B001EP>......DE....FRGB..IT............................................................</B001EP><B005EP>J</B005EP><B007EP>DIM360 (Ver 1.5  21 Nov 2005) -  2999001/0</B007EP></eptags></B000><B100><B110>1074626</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B9</B130><B132EP>B1</B132EP><B140><date>20060719</date></B140><B150><B151>W1</B151><B155><B1551>de</B1551><B1552>Ansprüche</B1552><B1551>en</B1551><B1552>Claims</B1552><B1551>fr</B1551><B1552>Revendications</B1552></B155></B150><B190>EP</B190></B100><B200><B210>00116623.0</B210><B220><date>20000801</date></B220><B240><B241><date>20021017</date></B241><B242><date>20031222</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>22146899</B310><B320><date>19990804</date></B320><B330><ctry>JP</ctry></B330></B300><B400><B405><date>20060719</date><bnum>200629</bnum></B405><B430><date>20010207</date><bnum>200106</bnum></B430><B450><date>20051123</date><bnum>200547</bnum></B450><B452EP><date>20050517</date></B452EP><B480><date>20060719</date><bnum>200629</bnum></B480></B400><B500><B510EP><classification-ipcr sequence="1"><text>C12N  15/53        19900101AFI20001128BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>C12N  15/60        19900101ALI20001128BHEP        </text></classification-ipcr><classification-ipcr sequence="3"><text>C12N   1/21        19900101ALI20001128BHEP        </text></classification-ipcr><classification-ipcr sequence="4"><text>C12N   9/02        19800101ALI20001128BHEP        </text></classification-ipcr><classification-ipcr sequence="5"><text>C12N   9/88        19800101ALI20001128BHEP        </text></classification-ipcr><classification-ipcr sequence="6"><text>C12P  13/08        19800101ALI20001128BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>Gene für L-Lysin biosynthese aus Thermophilen Bakterien</B542><B541>en</B541><B542>Genes for lysine biosynthetic system derived from thermophilic bacteria</B542><B541>fr</B541><B542>Gènes de bactérie thermophile pour la production de L-lysine</B542></B540><B560><B561><text>EP-A- 0 841 395</text></B561><B561><text>WO-A-99/20783</text></B561><B561><text>US-A- 5 426 052</text></B561><B562><text>DATABASE SWALL [Online] Q04796, 1 October 1993 (1993-10-01) "DIHYDRODIPICOLINATE SYNTHASE (EC 4.2.1.52) (DHDPS)" XP002189015</text></B562><B562><text>DATABASE SWALL [Online] P42976, 1 November 1995 (1995-11-01) "DIHYDRODIPICOLINATE REDUCTASE (EC 1.3.1.26) (DHPR)" XP002189016</text></B562><B562><text>EGGELING L ET AL: "IMPROVED L-LYSINE YIELD WITH CORYNEBACTERIUM GLUTAMICUM: USE OF DAPA RESULTING IN INCREASED FLUX COMBINED WITH GROWTH LIMITATION" APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, SPRINGER VERLAG, BERLIN, DE, vol. 49, no. 1, 1998, pages 24-30, XP000918549 ISSN: 0175-7598</text></B562><B562><text>MILLS DAVID A ET AL: "Cloning and sequence analysis of the mesodiaminopimelate decarboxylase gene from Bacillus methanolicus MGA3 and comparison to other decarboxylase genes." APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 59, no. 9, 1993, pages 2927-2937, XP001056318 ISSN: 0099-2240</text></B562><B562><text>SCHENDEL F J ET AL: "CLONING AND NUCLEOTIDE SEQUENCE OF THE GENE CODING FOR ASPARTOKINASE II FROM A THERMOPHILIC METHYLOTROPHIC BACILLUS SP" APPLIED AND ENVIRONMENTAL MICROBIOLOGY, WASHINGTON,DC, US, vol. 58, no. 9, September 1992 (1992-09), pages 2806-2814, XP002929561 ISSN: 0099-2240</text></B562><B562><text>LEE ET AL: "Lysine Production from Methanol at 50 DEG C Using Bacillus methanolicus: Modeling Volume Control, Lysine Concentration, and Productivity Using a Three-Phase Continuous Simulation" BIOTECHNOLOGY AND BIOENGINEERING, INTERSCIENCE PUBLISHERS, LONDON, GB, vol. 49, 4 October 1996 (1996-10-04), pages 639-653, XP002090188 ISSN: 0006-3592</text></B562></B560></B500><B600><B620EP><parent><cdoc><dnum><anum>05017544.7</anum><pnum>1621624</pnum></dnum><date>20050811</date></cdoc></parent></B620EP></B600><B700><B720><B721><snm>Tsujimoto, Nobuharu,
c/o Ajinomoto Co., Inc.</snm><adr><str>Ferm.&amp;Biotech.Labs,
1-1, Suzuki-cho,,
Kawasaki-ku</str><city>Kawasaki-shi,
Kanagawa</city><ctry>JP</ctry></adr></B721><B721><snm>Yasueda, Hisashi,
c/o Ajinomoto Co., Inc.</snm><adr><str>Ferm.&amp;Biotech.Labs,
1-1, Suzuki-cho,,
Kawasaki-ku</str><city>Kawasaki-shi,
Kanagawa</city><ctry>JP</ctry></adr></B721><B721><snm>Kawahara, Yoshio,
c/o Ajinomoto Co., Inc.</snm><adr><str>Ferm.&amp;Biotech.Labs,
1-1, Suzuki-cho,,
Kawasaki-ku</str><city>Kawasaki-shi,
Kanagawa</city><ctry>JP</ctry></adr></B721><B721><snm>Sugimoto, Shinichi,
c/o Ajinomoto Co., Inc.</snm><adr><str>Ferm.&amp;Biotech.Labs,
1-1, Suzuki-cho,,
Kawasaki-ku</str><city>Kawasaki-shi,
Kanagawa</city><ctry>JP</ctry></adr></B721></B720><B730><B731><snm>Ajinomoto Co., Inc.</snm><iid>02528370</iid><irf>EPA-53428</irf><adr><str>15-1, Kyobashi 1-chome, 
Chuo-ku</str><city>Tokyo</city><ctry>JP</ctry></adr></B731></B730><B740><B741><snm>Strehl Schübel-Hopf &amp; Partner</snm><iid>00100941</iid><adr><str>Maximilianstrasse 54</str><city>80538 München</city><ctry>DE</ctry></adr></B741></B740></B700><B800><B840><ctry>DE</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>IT</ctry></B840><B880><date>20020502</date><bnum>200218</bnum></B880></B800></SDOBI><!-- EPO <DP n="1"> -->
<description id="desc" lang="en">
<heading id="h0001"><b><u style="single">BACKGROUND OF THE INVENTION</u></b></heading>
<heading id="h0002"><u style="single">Field of the Invention</u></heading>
<p id="p0001" num="0001">The present invention relates to dihydrodipicolinate synthase and dihydrodipicolinate reductase derived from thermophilic Bacillus bacteria and genes coding for them.</p>
<heading id="h0003"><u style="single">Related Art</u></heading>
<p id="p0002" num="0002">In the production of L-lysine by fermentation, strains isolated from nature or artificial mutants thereof have been used in order to improve the productivity. Many artificial mutant strains that produce L-lysine are known, and many of them are aminoethylcysteine (AEC) resistant strains and belong to the genus <i>Brevibacterium</i>, <i>Corynebacterium</i>, <i>Bacillus</i> or <i>Escherichia</i>. Further, various techniques have been disclosed for increasing the amino acid production, for example, use of a transformant obtained by using recombinant DNA, (U.S. Patent No. 4,278,765).</p>
<p id="p0003" num="0003">Dihydrodipicolinate synthase (abbreviated as "DDPS" hereinafter) is an enzyme that synthesizes dihydrodipicolinate through dehydration condensation of aspartic acid semialdehyde and pyruvic acid, and this<!-- EPO <DP n="2"> --> reaction serves as an entrance of the branching into the L-lysine biosynthesis system in the biosynthesis of amino acids of aspartic acid type. Further, dihydrodipicolinate reductase (abbreviated as "DDPR" hereinafter) is known as one of important enzymes of the L-lysine biosynthesis system, which catalyzes the reaction in which the dihydrodipicoliniate generated in the aforementioned reaction is reduced to generate piperidinedicarboxylic acid.</p>
<p id="p0004" num="0004">As for microorganisms belonging to the genus <i>Escherichia</i> or <i>Corynebacterium</i>, the gene (<i>dapA</i>) which codes for DDPS has been cloned, and the nucleotide sequence thereof has also be determined. As for the genus <i>Escherichia</i>, methods for producing L-lysine by enhancing DDPS have been disclosed in Japanese Patent Laid-open Publication (Kokai) No. 56-18596/1981, U.S. Patent No. 4,346,170 and Applied Microbiology and Biotechnology, 15, pp.227-331 (1982). Furthermore, a method for producing L-lysine using an <i>Escherichia</i>, bacterium introduced with DDPS derived form <i>Corynebacterium</i> bacteria, which is known not to suffer feedback inhibition by L-lysine, has been disclosed in Korean Patent Publication No. 92-8382.</p>
<p id="p0005" num="0005">The gene coding for DDPR (<i>dapB</i>) has also been already obtained from the genus <i>Escherichia</i> (Bouvier, J. et al., <i>J. Biol. Chem</i>., <i>259</i>, 14829 (1984)) and the genus <i>Corynebacterium</i> (<i>Journal of Bacteriology, 175</i> (9), 2743-2749<!-- EPO <DP n="3"> --> (1993)). Furthermore, there has also been disclosed a method for improving production rate and productivity of L-lysine by enhancing the <i>dapB</i> gene derived from <i>Corynebacterium</i> bacterium together with the aspartokinase gene (WO96/40934).</p>
<p id="p0006" num="0006">The current mainstream of the L-lysine production is the fermentative production by using a coryneform bacterium or an <i>Escherichia</i> bacterium. In this production, however, enzymes required for the fermentation may be inactivated or the production bacteria may be killed due to temperature increase in the medium during the fermentation, and thus it is necessary to cool the medium during the fermentation.</p>
<p id="p0007" num="0007">By the way, enzymes and proteins produced by thermophilic bacteria are generally stable at elevated temperatures, and also stable against pH variation or organic solvents. Therefore, applications thereof as diagnostic regents, industrial catalysts and so forth have been highly developed. If it becomes possible to produce L-lysine by fermentation at elevated temperatures by utilizing such stability and durability of enzymes derived from thermophilic bacteria, the cooling of the medium becomes unnecessary, and therefore the cost for cooling during the fermentation can be reduced. Moreover, if fermentation at elevated temperatures is realized, it is expected that the reaction rate may also be improved<!-- EPO <DP n="4"> --></p>
<p id="p0008" num="0008">DATABASE SWALL [Online] Q04796, 1 October 1993 "Dihydrodipicolinate Synthase (EC 4.2.1.52 (DHDPS)", XP002189015, discloses dihydrodipicolinate synthase from B. subtilis.</p>
<p id="p0009" num="0009">EP 841 395 Al discloses a method for producing L-lysine in <i>Brevibacterium lactofermentum</i> which has been genetically modified by introduction of the dapA gene which codes for dihydrodipicolinate synthase.<!-- EPO <DP n="5"> --></p>
<heading id="h0004"><u style="single">SUMMARY OF THE INVENTION</u></heading>
<p id="p0010" num="0010">The present invention is accomplished in view of the aforementioned technical aspect, and its object is to obtain genes of the L-lysine biosynthesis system of thermophilic bacteria and thereby provide novel methods for producing L-lysine.</p>
<p id="p0011" num="0011">The inventors of the present invention assiduously studied in order to achieve the aforementioned object. As a result, they successfully isolated genes that code for DDPS and DDPR from <i>Bacillus methanolicus</i>, which is one of the thermophilic <i>Bacillus</i> bacteria, and determined the nucleotide sequences of these genes. Thus, they accomplished the present invention.</p>
<p id="p0012" num="0012">That is, the present invention provides the followings.
<ul id="ul0001" list-style="none" compact="compact">
<li>(1) A protein defined in the following (A) or (B):
<ul id="ul0002" list-style="none" compact="compact">
<li>(A) a protein which has the amino acid sequence of SEQ ID NO: 2 shown in the Sequence Listing, or</li>
<li>(B) a protein which has an amino acid sequence of SEQ ID NO: 2 shown in the sequence Listing including substitution, deletion, insertion, addition or inversion of not more than 50 amino acids, and has dihydrodipicolinate synthase activity.</li>
</ul></li>
<li>(2) A DNA which codes for a protein defined in the following (A) or (B):<!-- EPO <DP n="6"> -->
<ul id="ul0003" list-style="none" compact="compact">
<li>(A) a protein which has the amino acid sequence of SEQ ID NO: 2 shown in the Sequence Listing, or</li>
<li>(B) a protein which has an amino acid sequence of SEQ ID NO: 2 shown in the Sequence Listing including substitution, deletion, insertion, addition or inversion of not more than 50 amino acids, and has dihydrodipicolinate synthase activity.</li>
</ul></li>
<li>(3) The DNA according to (2), which is a DNA defined in the following (a) or (b):
<ul id="ul0004" list-style="none">
<li>(a) a DNA which has a nucleotide sequence comprising at least the nucleotide sequence of the nucleotide numbers 1 to 924 in SEQ ID NO: 1 shown in the Sequence Listing; or</li>
<li>(b) a DNA which is hybridizable with a nucleotide sequence comprising at least the nucleotide sequence of the nucleotide numbers 1 to 924 in SEQ ID NO: 1 shown in the Sequence Listing under a stringent condition, and codes for a protein having dihydrodipicolinate synthase activity.</li>
</ul></li>
<li>(4) The DNA according to (3), wherein the stringent condition is a condition in which washing is performed at 60°C, 1 x SSC and 0.1% SDS.<!-- EPO <DP n="7"> --> substitution, deletion, insertion, addition or inversion of one or several amino acids, and has dihydrodipicolinate reductase activity.</li>
<li>(5) A protein defined in the following (A) or (B) :
<ul id="ul0005" list-style="none">
<li>(A) a protein which has the amino acid sequence of SEQ ID NO: 2 shown in the Sequence Listing, or</li>
<li>(B) a protein which has an amino acid sequence of SEQ ID NO: 2 shown in the Sequence Listing including substitution, deletion, insertion, addition or inversion of not more than 10 amino Acids, and has dihydrodipicolinate synthase activity.</li>
</ul></li>
<li>(6) A DNA which codes for protein defined in the following (A) or (B):
<ul id="ul0006" list-style="none" compact="compact">
<li>(A) a protein which has the amino acid sequence of SEQ ID NO: 2 shown in the Sequence Listing, or</li>
<li>(B) a protein which has an amino acid sequence of SEQ ID NO: 2 shown in the Sequence Listing including substitution, deletion, insertion, addition or inversion of not more than 10 amino acids, and has dihydrodipicolinate synthase activity.<!-- EPO <DP n="8"> --><!-- EPO <DP n="9"> --></li>
<li>(7) A microorganism which is introduced with the DNA according to (2) in a form that allows expression of a protein encoded by the DNA.</li>
<li>(8) A method for producing L-lysine, which comprises culturing the microorganism according to (7) in a medium to produce and accumulate L-lysine in the medium, and collecting the L-lysine from the medium.</li>
</ul></li>
</ul></p>
<p id="p0013" num="0013">In the present invention, the expression of "to have dihydrodipicolinate synthase activity" is used to mean to have an activity for catalyzing the reaction of dehydration condensation of aspartic acid semialdehyde and pyruvic acid to generate dihydrodipicolinate. The expression of "to have dihydrodipicolinate reductase activity" is used to mean to have an activity for catalyzing the reaction of reduction of dihydrodipicolinate to generate piperidinedicarboxylic acid, and to mean that the activity is higher at 50°C than at 37°C.</p>
<p id="p0014" num="0014">According to the present invention, there is provided DDPS, which is involved in the L-lysine biosynthesis, with excellent heat resistance, and genes coding for them.</p>
<heading id="h0005"><u style="single">PREFERRED EMBODIMENTS OF THE INVENTION</u></heading>
<p id="p0015" num="0015">Hereafter, the present invention will be explained<!-- EPO <DP n="10"> --> in detail.</p>
<p id="p0016" num="0016">The DNA of the present invention can be obtained through selection of clones containing a DDPS gene based on recovery of auxotrophy in mutant strains of microorganisms deficient in DDPS used as an index from a gene library of thermophilic <i>Bacillus</i> bacteria, for example, <i>Bacillus methanolicus</i>.</p>
<p id="p0017" num="0017">The method for obtaining the DNA of the present invention will be explained below.</p>
<heading id="h0006">&lt;1&gt; Production of gene library of <i>Bacillus methanolicus</i></heading>
<p id="p0018" num="0018">A gene library of <i>Bacillus methanolicus</i> can be produced, for example, as follows. First, the total chromosome DNA is prepared by the method of Saito <i>et al.</i> (Saito, H. and Miura, K., <i>Biochem. Biophys. Acta, 72,</i> 619-629, (1963)) or the like from a wild-type strain of <i>Bacillus methanolicus</i>, for example, <i>Bacillus methanolicus</i> PB1 (NCIMB13113) strain, and partially digested with a suitable restriction enzyme, for example, Sau3AI and so forth to obtain a mixture of various fragments. If the degree of the digestion is controlled by adjusting digestion reaction time and so forth, restriction enzymes of a wide range can be used.</p>
<p id="p0019" num="0019">Subsequently, the digested chromosome DNA fragments are ligated to vector DNA autonomously replicable within <i>Escherichia coli</i> cells to produce recombinant DNA. More specifically, a restriction<!-- EPO <DP n="11"> --> enzyme producing the same end nucleotide sequence as the restriction enzyme used for the digestion of the chromosome DNA is allowed to act on the vector DNA to fully digest the vector and cleave it. Then, the mixture of the chromosome DNA fragments and the cleaved vector DNA obtained as described above are mixed, and a DNA ligase, preferably T4 DNA ligase, is allowed to act on the mixture to obtain recombinant DNA.</p>
<p id="p0020" num="0020">By using the obtained recombinant DNA, <i>Escherichia coli</i>, for example, the <i>Escherichia coli</i> JM109 strain and so forth, is transformed, and a gene library solution can be prepared from culture of obtained transformants. The transformation can be performed by, for example, the method of D.M. Morrison (Methods in Enzymology, 68, 326 (1979)) and the method in which recipient cells are treated with calcium chloride so as to increase the permeability of the cells for DNA (Mandel, M. and Higa, A., J. Mol. Biol., 53, 159 (1970)). Electroporation was employed in the examples mentioned below.</p>
<p id="p0021" num="0021">Examples of the vector include, for example, pUC19, pUC18, pBR322, pHSG299, pHSG298, pHSG399, pHSG398, RSF1010, pMW119, pMW118, pMW219, pMW218, pSTV28 and so forth. In addition, phage vectors can also be used. For example, since a chloramphenicol resistance gene is contained in pSTV28, only transformants harboring the vector or the recombinant DNA can be grown by using a medium containing chloramphenicol when that vector is<!-- EPO <DP n="12"> --> used.</p>
<p id="p0022" num="0022">Examples of the method for collecting the recombinant DNA from the cells after the transformants are cultured include the alkali SDS method and so forth.</p>
<heading id="h0007">&lt;2&gt; Screening of clones containing DDPS gene</heading>
<p id="p0023" num="0023">By using a gene library solution of <i>Bacillus methanolicus</i> obtained as described above, a mutant strain of microorganism deficient in DDPS is transformed, and clones showing recovery of auxotrophy are selected. Examples of such a mutant strain of microorganism deficient in DDPS include the <i>Escherichia coli</i> AT998 (CGSC4548) strain, which is deficient in DDPS. Since the <i>Escherichia coli</i> AT998 strain is deficient in the DDPS gene, it cannot grow in a minimal medium that does not contain diaminopimelate. On the other hand, a transformant strain thereof which harbors the DDPS gene derived from <i>Bacillus methanolicus</i> can grow in the minimal medium, because the gene functions. Therefore, a DNA fragment containing the DDPS gene can be obtained by selecting a transformant strain that can grow in the minimal medium and collecting recombinant DNA from the strain.<!-- EPO <DP n="13"> --></p>
<p id="p0024" num="0024">By extracting an inserted DNA fragment from the obtained recombinant DNA and determining nucleotide sequence of the fragment, the nucleotide sequence and the amino acid sequence of the DDPS gene and DDPS can be determined.</p>
<p id="p0025" num="0025">Determination of nucleotide sequences, digestion and ligation of DNA and so forth may be attained by those methods commonly used for gene cloning (detailed in, for example, Sambrook J., Fritsch, E.F. and Maniatis, T., 1989, Molecular Cloning: A Laboraroty Manual, Second edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY etc.). They can also be conducted<!-- EPO <DP n="14"> --> according to instructions attached to reagents such as restriction enzymes and kits.</p>
<p id="p0026" num="0026">The DDPS gene of the present invention codes for DDPS that has the amino acid sequence of SEQ ID NO: 2 shown in Sequence Listing. Specific examples of the DDPS gene of the present invention include DNA that has the nucleotide sequence of SEQ ID NO: 1. Further, the DDPS gene of the present invention may have a nucleotide sequence including replacement of codons for each amino acid with equivalent codons, so long as the sequence codes for the same amino acid sequence as the amino acid sequence shown as SEQ ID NO: 2.</p>
<p id="p0027" num="0027">Further, the DDPS gene of the present invention may be one coding for a protein which has an amino acid sequence of SEQ ID NO: 2 including substitution, deletion, insertion, addition or inversion of one or several amino acids, or one coding for a protein which has DDPS activity. The term "several" amino acids used herein means. 1-50 amino acids, more preferably 1-10 amino acids. Homology between the DDPS gene of the present invention and a known DDPS gene of <i>Bacillus subtilis</i> (<i>B. subtilis</i>) is 65.9% on the basis of the nucleotide sequence, and 64.8% on the basis of the encoded amino acid sequence.<!-- EPO <DP n="15"> --></p>
<p id="p0028" num="0028">DNA that codes for the substantially same protein as DDPS as described above is obtained by modifying the nucleotide sequence, for example, by means of the site-directed mutagenesis method so that one or more amino acid residues at a specific site should contain substitution, deletion, insertion, addition or inversion. DNA modified as described above may also be obtained by conventionally known mutation treatments.<!-- EPO <DP n="16"> --> Such mutation treatments includes a method for treating DNA coding for DDPS in vitro, for example, with hydroxylamine or the like, and a method for treating a microorganism, for example, a bacterium belonging to the genus <i>Escherichia</i>, harboring DNA coding for DDPS with ultraviolet irradiation or a mutagenizing agent usually used for the mutation treatment such as N-methyl-N'-nitro-N-nitrosoguanidine (NTG) and nitrous acid.</p>
<p id="p0029" num="0029">The substitution, deletion, insertion, addition, or inversion of nucleotides as described above also includes mutation (mutant or variant) which naturally occurs, for example, due to the individual difference or the difference in species or genus of the microorganism that harbors DDPS.</p>
<p id="p0030" num="0030">Such DNA coding for substantially the same protein as DDPS is obtained by expressing DNA having mutation described above in an appropriate cell, and investigating the DDPS activity of the expression product. DNA coding for substantially the same protein as DDPS is also obtained by isolating DNA which is hybridizable with a nucleotide sequence comprising the nucleotide sequence of SEQ ID NO: 1 shown in Sequence Listing or a part thereof, for example, a probe which can be prepared from the nucleotide sequence of SEQ ID NO: 1 by PCR, under a stringent condition, and codes for a protein having DDPS<!-- EPO <DP n="17"> --> activity.</p>
<p id="p0031" num="0031">The "stringent condition" referred to herein is a condition under which a so-called specific hybrid is formed, and a non-specific hybrid is not formed. It is difficult to clearly define this condition by using numerical values. However, for example, the stringent condition includes a condition under which DNA's having high homology, for example, DNA's having homology of not less than 40% are hybridized with each other, and DNA's having homology lower than the above are not hybridized with each other. Alternatively, the stringent condition is exemplified by a condition under which DNA's are hybridized with each other at a salt concentration corresponding to an ordinary condition of washing in Southern hybridization, i.e., 60°C, 1 x SSC, 0.1 % SDS, preferably 0.1 x SSC, 0.1 % SDS (see, for example, Sambrook, J., Fritsch, E.F. and Maniatis, T., Molecular Cloning: A Laboratory Manual, Second edition, 1989, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY etc.).</p>
<p id="p0032" num="0032">Such genes, which are hybridizable under the condition as described above, includes those having a stop codon generated in a coding region of the genes, and those having no activity due to mutation of active center. However, such mutants can be easily removed by ligating the genes with a commercially available activity expression vector, and measuring the DDPS<!-- EPO <DP n="18"> --> activity. The DDPS activity can be measured by, for example, the method of Yugari et al. (Yugari Y. and Gilvarg C., <i>Journal of Biological Chemistry, 240,</i> 4710 (1962)). Specifically, for example, the DDPS activity can be measured by allowing a reaction of 100 µl of 500 mM imidazole hydrochloride (pH 7.5), 100 µl of 20 mM aspartic acid semialdehyde (which can be synthesized by the method described in Black S. and Write N., <i>Journal of Biological Chemistry, 213</i>, 51 (1955)), 100 µl of 20 mM sodium pyruvate and 100 µl of an enzyme solution in a total volume of 1 ml and measuring increase of absorbance at 270 nm.</p>
<p id="p0033" num="0033">Because the nucleotide sequences of the genes which code for DDPS derived from Bacillus <i>methanolicus</i> were elucidated by the present invention, the DNA sequence which codes for DDPS can be obtained from <i>Bacillus methanolicus</i> gene library by hybridization using an oligonucleotide probe prepared<!-- EPO <DP n="19"> --> based on each of the sequences. DNA sequences which code for the enzymes can also be obtained by amplification from <i>Bacillus methanolicus</i> chromosome DNA by PCR (polymerase chain reaction) using oligonucleotide primers prepared based on the aforementioned nucleotide sequences.</p>
<heading id="h0008">&lt;3&gt; Application of DDPS gene</heading>
<p id="p0034" num="0034">The DDPS gene of the present invention can be used for production of DDPS. That is, DDPS can be produced by introducing DNA containing the DDPS gene into a suitable host cell, and culturing the obtained transformant to allow expression of the DNA. The produced DDPS protein can be collected from the culture and purified by techniques used for usual purification of proteins such as salting out, solvent precipitation, gel filtration chromatography and ion exchange chromatography.</p>
<p id="p0035" num="0035">The DDPS gene can also be utilized for breeding of L-lysine producing bacteria. By introducing the DDPS gene into a microorganism, L-lysine biosynthesis is enhanced and thus L-lysine producing ability is improved.</p>
<p id="p0036" num="0036">Examples of the host cell into which the DDPS gene<!-- EPO <DP n="20"> --> is introduced include <i>Escherichia</i> bacteria such as <i>Escherichia coli</i>, coryneform bacteria such as <i>Brevibacterium lactofermentum</i>, <i>Bacillus</i> bacteria such as <i>Bacillus methanolicus</i> and so forth. Examples of the vector used for introducing the DDPS gene into these hosts include, as for Escherichia bacteria, those mentioned above. As for coryneform bacteria, the following vectors can be mentioned. There are indicated microorganisms which harbors each vector, and accession numbers thereof at international depositories are shown in the parentheses, respectively.
<ul id="ul0007" list-style="none" compact="compact">
<li>pAJ655 <i>Escherichia coli</i> AJ11882 (FERM BP-136) <i>Corynebacterium glutamicum</i> SR8201 (ATCC39135)</li>
<li>pAJ1844 <i>Escherichia coli</i> AJ11883(FERM BP-137) <i>Corynebacterium glutamicum</i> SR8202 (ATCC39136)</li>
<li>pAJ611 <i>Escherichia coli</i> AJ11884 (FERM BP-138)</li>
<li>pAJ3148 <i>Corynebacterium glutamicum</i> SR8203 (ATCC39137)</li>
<li>pAJ440 <i>Bacillus subtilis</i> AJ11901 (FERM BP-140)</li>
</ul></p>
<p id="p0037" num="0037">These vectors are obtained from deposited microorganisms as follows. Cells collected at the logarithmic growth phase are lysed with lysozyme and SDS to give a lysate, from which a supernatant solution is obtained by centrifugation at 30,000 x g. Polyethylene<!-- EPO <DP n="21"> --> glycol is added to the supernatant solution to perform fractional purification by means of cesium chloride-ethidium bromide equilibrium density gradient centrifugation.</p>
<p id="p0038" num="0038">In order to introduce a plasmid into <i>E</i>. <i>coli</i> to transform it, there may be used a method in which recipient cells are treated with calcium chloride so as to increase the permeability of the cells for DNA (Mandel, M. and Higa, A., <i>J</i>. <i>Mol</i>. <i>Biol., 53</i>, 159 (1970)) and so forth.</p>
<p id="p0039" num="0039">Examples of the vector for <i>Bacillus</i> bacteria include, for example, pUB110, pHY300PLK, pHV1248, pE194, pC194, pBC16, pSA0501, pSA2100, pAM77, pT181, pBD6, pBD8, pBD64, pHV14 and so forth.</p>
<p id="p0040" num="0040">Transformation of coryneform bacteria may be performed by the electric pulse method (Sugimoto et al., Japanese Patent Publication Laid-Open No. 2-207791/1990). Transformation of <i>Bacillus</i> bacteria may be performed by a method of making host sells into the protoplast or spheroplast followed by introducing recombinant DNA into the DNA-recipient cells (Chang, S. and Choen, S.N., <i>Molec</i>. <i>Gen</i>. <i>Genet., 168</i>, 111 (1979); Bibb, M.J., Ward, J.M. and Hopwood, O.A., <i>Nature, 274,</i> 398 (1978); Hinnen, A., Hicks, J.B. and Fink, G.R., <i>Proc</i>. <i>Natl</i>. <i>Acad. Sci</i>., <i>USA, 75</i>, 1929 (1978)).</p>
<p id="p0041" num="0041">The DDPS gene to be introduced may be introduced into a host with a promoter proper to<!-- EPO <DP n="22"> --> the gene, or the structural gene ligated to another promoter may be introduced. Examples of such a promoter include lac promoter, trp promoter, trc promoter, tac promoter, P<sub>R</sub> promoter and P<sub>L</sub> promoter of λ phage, tet promoter, amyE promoter, spac promoter and so forth.</p>
<p id="p0042" num="0042">L-lysine can be produced by culturing a microorganism introduced with the DDPS gene and having L-lysine producing ability in a medium to produce and accumulate L-lysine in the medium, and collecting the L-lysine from the medium.</p>
<p id="p0043" num="0043">Although medium and culture conditions can suitably be selected according to kind of the host microorganism to be used, usual media can be used, which contain a nitrogen source, inorganic ions and other organic trace amount nutrients as required.</p>
<p id="p0044" num="0044">As the carbon source, there can be used saccharides such as glucose, lactose, galactose, fructose and hydrolysate of starch, alcohols such as glycerol and sorbitol, organic acids such as fumaric acid, citric acid and succinic acid and so forth.</p>
<p id="p0045" num="0045">When a methanol assimilating bacterium such as <i>Bacillus methanolicus</i> is used as the microorganism of the present invention, methanol can be preferably used as the carbon source.</p>
<p id="p0046" num="0046">As the nitrogen source, inorganic ammonium salts such as ammonium sulfate, ammonium chloride and ammonium<!-- EPO <DP n="23"> --> phosphate, organic nitrogen such as soybean hydrolysate, ammonia gas, aqueous ammonia and so forth can be used.</p>
<p id="p0047" num="0047">As the inorganic ions or sources thereof, a small amount of potassium phosphate, magnesium sulfate, iron ions, manganese ions and so forth may be added. As a trace amount organic nutrient, it is desirable to add a suitable amount of required substances such as L-homoserine and vitamin B<sub>1</sub>, yeast extract and so forth as required.</p>
<p id="p0048" num="0048">The culture is performed under conditions suitable for growth of a microorganism to be used. In general, it is preferably performed for 16 to 72 hours under an aerobic condition, and the culture temperature is controlled to be 20 to 45°C, and pH to be 5-8.5 during the culture. For adjusting pH, inorganic or organic acidic or alkaline substances, ammonia gas and so forth can be used. Further, when a thermophilic bacterium is used as a host, it can be cultured at a culture temperature of 42 to 60°C.</p>
<p id="p0049" num="0049">Collection of L-lysine from the culture can usually be carried out by using a combination of known techniques such as techniques using ion exchange resins, precipitation methods and so forth.</p>
<heading id="h0009"><u style="single">EXAMPLES</u></heading>
<p id="p0050" num="0050">Hereafter, the present invention will be further<!-- EPO <DP n="24"> --> specifically explained with reference to the following examples.</p>
<p id="p0051" num="0051">The reagents used were obtained from Wako Pure Chemicals or Nakarai Tesque unless otherwise indicated. The compositions of the media used in each example are shown below. All the media were subjected to steam sterilization at 120°C for 20 minutes after the components were dissolved.
<tables id="tabl0001" num="0001">
<table frame="all">
<tgroup cols="2" colsep="1" rowsep="0">
<colspec colnum="1" colname="col1" colwidth="37mm"/>
<colspec colnum="2" colname="col2" colwidth="13mm"/>
<thead valign="top">
<row rowsep="1">
<entry namest="col1" nameend="col1" align="left" valign="top">[L medium]</entry>
<entry namest="col2" nameend="col2" align="left" valign="top"/></row></thead>
<tbody valign="top">
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">Bacto trypton (DIFCO)</entry>
<entry namest="col2" nameend="col2" align="left" valign="top">1%</entry></row>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">Yeast extract (DIFCO)</entry>
<entry namest="col2" nameend="col2" align="left" valign="top">0.5%</entry></row>
<row rowsep="1">
<entry namest="col1" nameend="col1" align="left" valign="top">NaCl</entry>
<entry namest="col2" nameend="col2" align="left" valign="top">0.5%</entry></row></tbody></tgroup>
</table>
</tables>
<tables id="tabl0002" num="0002">
<table frame="all">
<tgroup cols="2" colsep="1" rowsep="1">
<colspec colnum="1" colname="col1" colwidth="33mm"/>
<colspec colnum="2" colname="col2" colwidth="13mm"/>
<thead valign="top">
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">[L agar medium]</entry>
<entry namest="col2" nameend="col2" rowsep="0" align="left" valign="top"/></row>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">L medium</entry>
<entry namest="col2" nameend="col2" align="left" valign="top"/></row></thead>
<tbody valign="top">
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">Bacto agar (DIFCO)</entry>
<entry namest="col2" nameend="col2" align="right" valign="top">1.5%</entry></row></tbody></tgroup>
</table>
</tables>
<tables id="tabl0003" num="0003">
<table frame="all">
<tgroup cols="2" colsep="1" rowsep="0">
<colspec colnum="1" colname="col1" colwidth="37mm"/>
<colspec colnum="2" colname="col2" colwidth="16mm"/>
<thead valign="top">
<row rowsep="1">
<entry namest="col1" nameend="col1" align="left" valign="top">[SOC medium]</entry>
<entry namest="col2" nameend="col2" align="left" valign="top"/></row></thead>
<tbody valign="top">
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">Bacto trypton (DIFCO)</entry>
<entry namest="col2" nameend="col2" align="right" valign="top">2%</entry></row>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">Yeast extract (DIFCO)</entry>
<entry namest="col2" nameend="col2" align="right" valign="top">0.5%</entry></row>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">NaCl</entry>
<entry namest="col2" nameend="col2" align="right" valign="top">10 mM</entry></row>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">KCl</entry>
<entry namest="col2" nameend="col2" align="right" valign="top">2.5 mM</entry></row>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">MgSO<sub>4</sub></entry>
<entry namest="col2" nameend="col2" align="right" valign="top">10 mM</entry></row>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">MgCl<sub>2</sub></entry>
<entry namest="col2" nameend="col2" align="right" valign="top">10 mM</entry></row>
<row rowsep="1">
<entry namest="col1" nameend="col1" align="left" valign="top">Glucose</entry>
<entry namest="col2" nameend="col2" align="right" valign="top">20 mM</entry></row></tbody></tgroup>
</table>
</tables></p>
<p id="p0052" num="0052">[The components except for magnesium solution and<!-- EPO <DP n="25"> --> glucose were steam-sterilized, then added with 2 M magnesium stock solution (1 M MgSO<sub>4</sub>, 1 M MgCl<sub>2</sub>) and 2 M glucose solution, which solutions had been passed through a 0.22 µm filter beforehand, and passed through a 0.22 µm filter again.]
<tables id="tabl0004" num="0004">
<table frame="all">
<tgroup cols="2" colsep="1" rowsep="0">
<colspec colnum="1" colname="col1" colwidth="37mm"/>
<colspec colnum="2" colname="col2" colwidth="13mm"/>
<thead valign="top">
<row rowsep="1">
<entry namest="col1" nameend="col1" align="left" valign="top">[TS medium]</entry>
<entry namest="col2" nameend="col2" align="left" valign="top"/></row></thead>
<tbody valign="top">
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">Bacto trypton (DIFCO)</entry>
<entry namest="col2" nameend="col2" align="center" valign="top">1.5%</entry></row>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">Bactosoyton (DIFCO)</entry>
<entry namest="col2" nameend="col2" align="center" valign="top">0.5%</entry></row>
<row rowsep="1">
<entry namest="col1" nameend="col1" align="left" valign="top">NaCl</entry>
<entry namest="col2" nameend="col2" align="center" valign="top">0.5%</entry></row></tbody></tgroup>
</table>
</tables>
<tables id="tabl0005" num="0005">
<table frame="all">
<tgroup cols="2" colsep="1" rowsep="1">
<colspec colnum="1" colname="col1" colwidth="33mm"/>
<colspec colnum="2" colname="col2" colwidth="13mm"/>
<thead valign="top">
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">[TS agar medium]</entry>
<entry namest="col2" nameend="col2" rowsep="0" align="left" valign="top"/></row>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">TS medium</entry>
<entry namest="col2" nameend="col2" align="left" valign="top"/></row></thead>
<tbody valign="top">
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">Bacto agar (DIFCO)</entry>
<entry namest="col2" nameend="col2" align="center" valign="top">1.5%</entry></row></tbody></tgroup>
</table>
</tables>
<tables id="tabl0006" num="0006">
<table frame="all">
<tgroup cols="2" colsep="1" rowsep="0">
<colspec colnum="1" colname="col1" colwidth="34mm"/>
<colspec colnum="2" colname="col2" colwidth="22mm"/>
<thead valign="top">
<row rowsep="1">
<entry namest="col1" nameend="col1" align="left" valign="top">[M9 minimal medium]</entry>
<entry namest="col2" nameend="col2" align="left" valign="top"/></row></thead>
<tbody valign="top">
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">Na<sub>2</sub>HPO<sub>4</sub>·•12H<sub>2</sub>O</entry>
<entry namest="col2" nameend="col2" align="left" valign="top">8%</entry></row>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">KH<sub>2</sub>PO<sub>4</sub></entry>
<entry namest="col2" nameend="col2" align="left" valign="top">1.5%</entry></row>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">NaCl</entry>
<entry namest="col2" nameend="col2" align="left" valign="top">2.5%</entry></row>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">NH<sub>4</sub>Cl</entry>
<entry namest="col2" nameend="col2" align="left" valign="top">0.5%</entry></row>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">MgSO<sub>4</sub>•7H<sub>2</sub>O</entry>
<entry namest="col2" nameend="col2" align="left" valign="top">246.48 mg/L</entry></row>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">Glucose</entry>
<entry namest="col2" nameend="col2" align="left" valign="top">0.5%</entry></row>
<row rowsep="1">
<entry namest="col1" nameend="col1" align="left" valign="top">pH 7.0</entry>
<entry namest="col2" nameend="col2" align="left" valign="top"/></row></tbody></tgroup>
</table>
</tables></p>
<p id="p0053" num="0053">[MgSO<sub>4</sub> and glucose were separately sterilized and added. A suitable amount of amino acids and vitamins were added as required.]<!-- EPO <DP n="26"> -->
<tables id="tabl0007" num="0007">
<table frame="all">
<tgroup cols="2" colsep="1" rowsep="0">
<colspec colnum="1" colname="col1" colwidth="42mm"/>
<colspec colnum="2" colname="col2" colwidth="13mm"/>
<tbody valign="top">
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">[M9 minimal agar medium]</entry>
<entry namest="col2" nameend="col2" align="left" valign="top"/></row>
<row>
<entry namest="col1" nameend="col1" align="left" valign="top">M9 minimal medium</entry>
<entry namest="col2" nameend="col2" align="left" valign="top"/></row>
<row rowsep="1">
<entry namest="col1" nameend="col1" align="left" valign="top">Bacto agar (DIFCO)</entry>
<entry namest="col2" nameend="col2" align="center" valign="top">1.5%</entry></row></tbody></tgroup>
</table>
</tables></p>
<heading id="h0010"><u style="single">Example 1 : Cloning of DDPS gene of <i>Bacillus methanolicus</i> PB1 strain</u></heading>
<heading id="h0011">(1) Preparation of chromosome DNA from <i>Bacillus methanolicus</i></heading>
<p id="p0054" num="0054">One loop of the <i>Bacillus methanolicus</i> PB1 strain (NCIMB13113) was inoculated into 5 ml of TS medium contained in a test tube, and cultured overnight at 50°C with shaking. The obtained culture was inoculated into 50 ml of TS medium contained in a 500-ml volume Sakaguchi flask at a concentration of 1%, and cultured at 50°C for 5-6 hours, and the cells were collected by centrifugation. The cells were suspended in 50 ml of TEN solution [solution comprising 50 mM Tris-HCl (pH 8.0), 10 mM EDTA, 20 mM NaCl (pH 8.0)], collected by centrifugation, and suspended again in 5 ml of TEN solution containing 5 mg/ml of lysozyme and 10 µg/ml of ribonuclease A.</p>
<p id="p0055" num="0055">The suspension was maintained at 37°C for 30 minutes, and then added with proteinase K and sodium laurylsulfate at final concentrations of 10 µg/ml and 0.5%, respectively. The suspension was maintained at 70°C for 2 hours, then added with an equal volume of a saturated phenol solution (phenol solution saturated<!-- EPO <DP n="27"> --> with 10 mM Tris-HCl (pH 8.0)), and centrifuged. The supernatant was collected, added and mixed with an equal volume of a phenol/chloroform solution (phenol:chloroform:isoamyl alcohol = 25:24:1), and centrifuged.</p>
<p id="p0056" num="0056">The supernatant was collected, and the same procedure as above was repeated by adding an equal volume of a chloroform solution (chloroform:isoamyl alcohol = 24:1). The supernatant was added with 1/10 volume of 3 M sodium acetate (pH 4.8) and 2.5-fold volume of ethanol to precipitate chromosome DNA. The precipitate was collected by centrifugation, washed with 70% ethanol, dried under vacuum, and dissolved in an appropriate amount of TE solution (10 mM Tris-HCl, 1 mM EDTA (pH 8.0)).</p>
<heading id="h0012">(2) Ligation of vector DNA and chromosome DNA</heading>
<p id="p0057" num="0057">50 µl of the chromosome DNA (1 µg/µl) obtained in the above (1), 20 µl of H buffer (500 mM Tris-HCl, 100 mM MgCl<sub>2</sub>, 10 mM dithiothreitol, 1000 mM NaCl (pH 7.5)) and 8 units of restriction enzyme Sau3AI (Takara Shuzo) were allowed to react in a total volume of 200 µl at 37°C for 10 minutes, and then the reaction mixture was mixed with 200 µl of the phenol/chloroform solution to stop the reaction.</p>
<p id="p0058" num="0058">The mixture was centrifuged to obtain an upper layer, which was separated on 0.8% agarose gel. A DNA<!-- EPO <DP n="28"> --> fragment corresponding to 2-8 kilo base pairs (abbreviated as "kbp" hereinafter) was collected from the gel using EASYTRAP (glass powder for collection of DNA, produced by Takara Shuzo) to obtain 50 µl of a fractionated DNA solution.</p>
<p id="p0059" num="0059">Separately, 5 µl of 0.5 µg/µl plasmid pSTV28 (produced by Takara Shuzo), 2 µl of K buffer (200 mM Tris-HCl, 100 mM MgCl<sub>2</sub>, 10 mM dithiothreitol, 1000 mM KCl (pH 8.5)) and 10 units of restriction enzyme BamHI (produced by Takara Shuzo) were allowed to react in a total volume of 20 µl at 37°C for 2 hours, then added with 20 units of calf small intestine alkaline phosphatase (produced by Takara Shuzo), and further allowed to react for 30 minutes. The reaction mixture was added and mixed with an equal volume of the phenol/chloroform solution, and centrifuged. The supernatant was collected, and the same procedure as above was repeated by adding an equal volume of the chloroform solution. The supernatant was added with 1/10 volume of 3 M sodium acetate (pH 4.8) and 2.5-fold volume of ethanol to precipitate DNA. The precipitate was collected by centrifugation, washed with 70% ethanol, dried under vacuum, and dissolved in TE solution.</p>
<p id="p0060" num="0060">The Sau3AI digest of the chromosome DNA fractionated in the above (1) and the BamHI digest of pSTV28 were ligated by using Ligation Kit ver. 2 (Takara Shuzo). The ligation reaction mixture was added with<!-- EPO <DP n="29"> --> 1/10 volume of 3 M sodium acetate (pH 4.8) and 2.5-fold volume of ethanol were added to precipitate DNA. The precipitate was collected by centrifugation, washed with 70% ethanol, dried under vacuum, and dissolved in TE solution.</p>
<heading id="h0013">(3) Preparation of gene library</heading>
<p id="p0061" num="0061">One loop of <i>Escherichia coli</i> JM109 was inoculated into 5 ml of L medium contained in a test tube, and cultured overnight at 37°C with shaking. The obtained culture was inoculated into 50 ml of L medium contained in a 500-ml volume Sakaguchi flask at a concentration of 1%, and cultured at 37°C until OD<sub>660</sub> reached 0.5-0.6. The culture was cooled on ice for 15 minutes, and centrifuged at 4°C to collect the cells. The cells were washed by suspending them in 50 ml of ice-cooled water and subjecting the suspension to centrifugation. This procedure was repeated once again, and the cells were washed by suspending them in 50 ml of 10% glycerol solution cooled with ice and subjecting the suspension to centrifugation. The cells were suspended in an equal volume of 10% glycerol solution, and divided into portions of 50 µl volume. To 50 µl of the cell, 1 µl of the ligation solution prepared above was added, and the mixture was transferred to a cuvette (for exclusive use in an electroporation apparatus of BioRad Co., width of 0.1 cm) cooled with ice beforehand. Conditions of the<!-- EPO <DP n="30"> --> electroporation apparatus were set at 1.8 kV and 25 µF, and the pulse controller was set at 200 ohms. The cuvette was mounted on the apparatus and pulse was applied. After the application of the pulse, the mixture was immediately added with 0.5 ml of SOC medium, transferred to a sterilized test tube, and cultured at 37°C for 1 hour with shaking. The culture was plated on L agar medium containing 20 µg/ml of chloramphenicol, and incubated overnight at 37°C.</p>
<p id="p0062" num="0062">The emerged colonies were collected by scraping, inoculated into 50 ml of L medium in a 500-ml volume Sakaguchi flask, and cultured at 37°C for 2 hours with shaking. Plasmid DNA was extracted from the cultured cells by the alkali SDS method to obtain a gene library solution.</p>
<heading id="h0014">(4) Isolation of clone with DDPS gene</heading>
<p id="p0063" num="0063">The <i>Escherichia coli</i> AT998 strain deficient in the DDPS gene (CGSC 4548) was transformed with the aforementioned gene library solution by electroporation as described above. After application of pulse, SOC medium was added to the transformation solution, and the cells were cultured at 37°C with shaking. The culture was centrifuged, and the cells were washed by suspending them in 5 ml of sterilized water and centrifuging the suspension. This washing procedure was repeated once again, and the cells were suspended in 500 µl of<!-- EPO <DP n="31"> --> sterilized water. The suspension was plated on M9 minimal agar medium containing 20 µg/ml of chloramphenicol, and incubated at 37°C for 2-3 days. Because the <i>Escherichia coli</i> AT998 strain is deficient in the DDPS gene, it cannot grow on M9 minimal medium not containing diaminopimelic acid. However, a transformant strain thereof which contains the DDPS gene derived from <i>Bacillus methanolicus</i> can grow on M9 minimal medium because the gene functions.</p>
<p id="p0064" num="0064">The recombinant vector was extracted from the emerged colonies, and the inserted fragment was confirmed. A transformant with the vector pSTV28 could not grow on M9 minimal medium, whereas the <i>Escherichia coli</i> AT998 strain transformed with the above recombinant plasmid grew on M9 minimal medium. Thus, it was confirmed that the obtained insert contained the DDPS gene.</p>
<p id="p0065" num="0065">The <i>Escherichia coli</i> AT998 strain which harbors the plasmid containing the DDPS gene obtained as described above was designated as <i>Escherichia coli</i> AJ13633. The AJ13633 strain was deposited at National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology, Ministry of International Trade and Industry (postal code 305-8566, 1-3 Higashi 1-chome, Tsukuba-shi, Ibaraki-ken, Japan) on July 26, 1999 as an accession number of FERM P-17485, and transferred from the original deposit to<!-- EPO <DP n="32"> --> international deposit based on Budapest Treaty on July 14, 2000, and has been deposited as deposition number of FERM BP-7221.</p>
<heading id="h0015">(5) Determination of nucleotide sequence of DDPS gene</heading>
<p id="p0066" num="0066">Plasmid containing the DDPS gene was prepared from the <i>Escherichia coli</i> AJ13633 strain, and the nucleotide sequence of the DDPS gene derived from the <i>Bacillus methanolicus</i> PB1 strain was determined by the dideoxy method. The coding region of the determined nucleotide sequence of the DDPS gene was shown as SEQ ID NO: 1. The amino acid sequence encoded by the nucleotide sequence is shown as SEQ ID NO: 2. Nucleotide and amino acid sequence were analyzed with the Genetyx-Mac computer program (Software Development Co., Tokyo, Japan). The homology analysis was carried out according to the method developed by Lipman and Peason (<i>Science</i>, <i>227</i>, 1435-1441, 1985). As a result of the homology search, since this amino acid sequence showed a high homology of 64.8% with respect to DDPS derived from <i>Bacillus subtilis</i> belonging to the genus <i>Bacillus</i> like <i>Bacillus methanolicus</i>, the obtained gene was identified to be the DDPS gene derived from <i>Bacillus methanolicus.</i><!-- EPO <DP n="33"> --></p>
<heading id="h0016">SEQUENCE LISTING</heading>
<p id="p0067" num="0067">
<ul id="ul0008" list-style="none">
<li>&lt;110&gt; Ajinomoto Co., Inc.</li>
<li>&lt;120&gt; Genes for Lysine Biosynthetic System Derived from Thermophilic Bacteria</li>
<li>&lt;130&gt; EPA-53428</li>
<li>&lt;140&gt;<br/>
&lt;141&gt;</li>
<li>&lt;150&gt; JP 11-221468<br/>
&lt;151&gt; 1999-08-04</li>
<li>&lt;160&gt; 4</li>
<li>&lt;170&gt; PatentIn Ver. 2.0</li>
<li>&lt;210&gt; 1<br/>
&lt;211&gt; 873<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Bacillus methanolicus</li>
<li>&lt;220&gt;<br/>
&lt;221&gt; CDS<br/>
&lt;222&gt; (1)..(870)</li>
<li>&lt;400&gt; 1
<img id="ib0001" file="imgb0001.tif" wi="147" he="48" img-content="dna" img-format="tif"/><!-- EPO <DP n="34"> -->
<img id="ib0002" file="imgb0002.tif" wi="146" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="35"> -->
<img id="ib0003" file="imgb0003.tif" wi="154" he="57" img-content="dna" img-format="tif"/></li>
<li>&lt;210&gt; 2<br/>
&lt;211&gt; 290<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Bacillus methanolicus</li>
<li>&lt;400&gt; 2
<img id="ib0004" file="imgb0004.tif" wi="137" he="149" img-content="dna" img-format="tif"/><!-- EPO <DP n="36"> -->
<img id="ib0005" file="imgb0005.tif" wi="147" he="78" img-content="dna" img-format="tif"/></li>
</ul></p>
</description><!-- EPO <DP n="37"> -->
<claims id="claims01" lang="en">
<claim id="c-en-01-0001" num="0001">
<claim-text>A protein defined in the following (A) or (B):
<claim-text>(A) a protein which has the amino acid sequence of SEQ ID NO: 2 shown in the Sequence Listing, or</claim-text>
<claim-text>(B) a protein which has an amino acid sequence of SEQ ID NO: 2 shown in the Sequence Listing including substitution, deletion, insertion, addition or inversion of not more than 50 amino acids, and has dihydrodipicolinate synthase activity.</claim-text></claim-text></claim>
<claim id="c-en-01-0002" num="0002">
<claim-text>A DNA which codes for a protein defined in the following (A) or (B):
<claim-text>(A) a protein which has the amino acid sequence of SEQ ID NO: 2 shown in the Sequence Listing, or</claim-text>
<claim-text>(B) a protein which has an amino acid sequence of SEQ ID NO: 2 shown in the Sequence Listing including substitution, deletion, insertion, addition or inversion of not more than 50 amino acids, and has dihydrodipicolinate synthase activity.</claim-text></claim-text></claim>
<claim id="c-en-01-0003" num="0003">
<claim-text>The DNA according to claim 2, which is a DNA defined in the following (a) or (b):
<claim-text>(a) a DNA which has a nucleotide sequence comprising at least the nucleotide sequence of the nucleotide numbers 1 to 924 in SEQ ID NO: 1 shown in the Sequence Listing; or</claim-text>
<claim-text>(b) a DNA which is hybridizable with a nucleotide sequence comprising at least the nucleotide sequence of<!-- EPO <DP n="38"> --> the nucleotide numbers 1 to 924 in SEQ ID NO: 1 shown in the Sequence Listing under a stringent condition, and codes for a protein having dihydrodipicolinate synthase activity.</claim-text></claim-text></claim>
<claim id="c-en-01-0004" num="0004">
<claim-text>The DNA according to claim 3, wherein the stringent condition is a condition in which washing is performed at 60°C, 1 x SSC and 0.1% SDS.<!-- EPO <DP n="39"> --></claim-text></claim>
<claim id="c-en-01-0005" num="0005">
<claim-text>A protein defined in the following (A) or (B):
<claim-text>(A) a protein which has the amino acid sequence of SEQ ID NO: 2 shown in the Sequence Listing, or</claim-text>
<claim-text>(B) a protein which has an amino acid sequence of SEQ ID NO: 2 shown in the Sequence Listing including substitution, deletion, insertion, addition or inversion of not more than 10 amino acids, and has dihydrodipicolinate synthase activity.</claim-text></claim-text></claim>
<claim id="c-en-01-0006" num="0006">
<claim-text>A DNA which codes for a protein defined in the following (A) or (B) :
<claim-text>(A) a protein which has the amino acid sequence of SEQ ID NO: 2 shown in the Sequence Listing, or</claim-text>
<claim-text>(B) a protein which has an amino acid sequence of SEQ ID NO: 2 shown in the Sequence Listing including substitution, deletion, insertion, addition or inversion of not more than 10 amino acids, and has dihydrodipicolinate synthase activity.</claim-text><!-- EPO <DP n="40"> --></claim-text></claim>
<claim id="c-en-01-0007" num="0007">
<claim-text>A microorganism which has introduced the DNA according to claim 2 in a form that allows expression of a protein encoded by the DNA.</claim-text></claim>
<claim id="c-en-01-0008" num="0008">
<claim-text>A method for producing L-lysine, which comprises culturing the microorganism according to claim 7 in a medium to produce and accumulate L-lysine in the medium, and collecting the L-lysine from the medium.</claim-text></claim>
</claims><!-- EPO <DP n="41"> -->
<claims id="claims02" lang="de">
<claim id="c-de-01-0001" num="0001">
<claim-text>Protein, das nachfolgend in (A) oder (B) definiert ist:
<claim-text>(A) Protein, welches die im Sequenzprotokoll gezeigte Aminosäuresequenz von SEQ ID NO: 2 aufweist, oder</claim-text>
<claim-text>(B) Protein, welches die im Sequenzprotokoll gezeigte Aminosäuresequenz von SEQ ID NO: 2 aufweist, einschließlich einer Substitution, Deletion, Insertion, Addition oder Inversion von nicht mehr als 50 Aminosäuren, und welches eine Dihydrodipicolinatsynthaseaktivität aufweist.</claim-text></claim-text></claim>
<claim id="c-de-01-0002" num="0002">
<claim-text>DNA, die für ein nachfolgend in (A) oder (B) definiertes Protein codiert:
<claim-text>(A) Protein, welches die im Sequenzprotokoll gezeigte Aminosäuresequenz von SEQ ID NO: 2 aufweist, oder</claim-text>
<claim-text>(B) Protein, welches die im Sequenzprotokoll gezeigte Aminosäuresequenz von SEQ ID NO: 2 aufweist, einschließlich einer Substitution, Deletion, Insertion, Addition oder Inversion von nicht mehr als 50 Aminosäuren, und welches eine Dihydrodipicolinatsynthaseaktivität aufweist.</claim-text></claim-text></claim>
<claim id="c-de-01-0003" num="0003">
<claim-text>DNA nach Anspruch 2, wobei die DNA wie nachfolgend in (a) oder (b) definiert ist:
<claim-text>(a) DNA, welche eine Nucleotidsequenz aufweist, umfassend zumindest die im Sequenzprotokoll in SEQ ID NO: 1 gezeigte Nucleotidsequenz der Nucleotidzahlen 1 bis 924; oder</claim-text>
<claim-text>(b) DNA, die unter stringenten Bedingungen mit einer Nucleotidsequenz hybridisierbar ist, umfassend zumindest die im Sequenzprotokoll in SEQ ID NO: 1 gezeigte Nucleotidsequenz der Nucleotidzahlen 1 bis 924, und die für ein Protein mit Dihydrodipicolinatsynthaseaktivität codiert.</claim-text></claim-text></claim>
<claim id="c-de-01-0004" num="0004">
<claim-text>DNA nach Anspruch 3, wobei die stringente Bedingung eine Bedingung ist, bei der ein Waschen bei 60°C, 1 x SSC und 0,1% SDS durchgeführt wird.<!-- EPO <DP n="42"> --></claim-text></claim>
<claim id="c-de-01-0005" num="0005">
<claim-text>Protein, das nachfolgend in (A) oder (B) definiert ist:
<claim-text>(A) Protein, welches die im Sequenzprotokoll gezeigte Aminosäuresequenz von SEQ ID NO: 2 aufweist, oder</claim-text>
<claim-text>(B) Protein, welches die im Sequenzprotokoll gezeigte Aminosäuresequenz von SEQ ID NO: 2 aufweist, einschließlich einer Substitution, Deletion, Insertion, Addition oder Inversion von nicht mehr als 10 Aminosäuren, und welches eine Dihydrodipicolinatsynthaseaktivität aufweist.</claim-text></claim-text></claim>
<claim id="c-de-01-0006" num="0006">
<claim-text>DNA, die für ein nachfolgend in (A) oder (B) definiertes Protein codiert:
<claim-text>(A) Protein, welches die im Sequenzprotokoll gezeigte Aminosäuresequenz von SEQ ID NO: 2 aufweist, oder</claim-text>
<claim-text>(B) Protein, welches die im Sequenzprotokoll gezeigte Aminosäuresequenz von SEQ ID NO: 2 aufweist, einschließlich einer Substitution, Deletion, Insertion, Addition oder Inversion von nicht mehr als 10 Aminosäuren, und welches eine Dihydrodipicolinatsynthaseaktivität aufweist.</claim-text></claim-text></claim>
<claim id="c-de-01-0007" num="0007">
<claim-text>Mikroorganismus, bei dem die DNA nach Anspruch 2 in einer Form eingeführt wurde, dass die Expression eines durch die DNA codierten Proteins ermöglicht wird.</claim-text></claim>
<claim id="c-de-01-0008" num="0008">
<claim-text>Verfahren zur Herstellung von L-Lysin, umfassend das Kultivieren des Mikroorganismus nach Anspruch 7 in einem Medium, um L-Lysin in dem Medium zu produzieren und zu akkumulieren, und Gewinnen des L-Lysins aus dem Medium.</claim-text></claim>
</claims><!-- EPO <DP n="43"> -->
<claims id="claims03" lang="fr">
<claim id="c-fr-01-0001" num="0001">
<claim-text>Protéine définie en (A) ou (B) suivant :
<claim-text>(A) une protéine qui a la séquence d'aminoacides de SEQ ID NO : 2 montrée dans le listage de séquences, ou</claim-text>
<claim-text>(B) une protéine qui a une séquence d'aminoacides de SEQ ID NO : 2 montrée dans le listage de séquences incluant une substitution, délétion, insertion, addition ou inversion d'au plus 50 aminoacides, et a une activité dihydrodipicolinate synthase.</claim-text></claim-text></claim>
<claim id="c-fr-01-0002" num="0002">
<claim-text>ADN qui code une protéine définie en (A) ou (B) suivant :
<claim-text>(A) une protéine qui a la séquence d'aminoacides de SEQ ID NO : 2 montrée dans le listage de séquences, ou</claim-text>
<claim-text>(B) une protéine qui a une séquence d'aminoacides de SEQ ID NO : 2 montrée dans le listage de séquences incluant une substitution, délétion, insertion, addition ou inversion d'au plus 50 aminoacides, et a une activité dihydrodipicolinate synthase.</claim-text></claim-text></claim>
<claim id="c-fr-01-0003" num="0003">
<claim-text>ADN selon la revendication 2 qui est un ADN défini en (a) ou (b) suivant :
<claim-text>(a) un ADN qui a une séquence nucléotidique comprenant au moins la séquence nucléotidique des nucléotides n° 1 à 924 dans SEQ ID NO : 1 montrée dans le listage de séquences ; ou</claim-text>
<claim-text>(b) un ADN qui est hybridable avec une séquence nucléotidique comprenant au moins la séquence nucléotidique des nucléotides n° 1 à 924 dans SEQ ID NO : 1 montrée dans le listage de séquences dans des conditions stringentes, et code une protéine ayant une activité dihydrodipicolinate synthase.</claim-text></claim-text></claim>
<claim id="c-fr-01-0004" num="0004">
<claim-text>ADN selon la revendication 3 où les conditions stringentes sont des conditions dans lesquelles un lavage est réalisé à 60°C, 1 x SSC et 0,1 % de SDS.</claim-text></claim>
<claim id="c-fr-01-0005" num="0005">
<claim-text>Protéine définie en (A) ou (B) suivant :
<claim-text>(A) une protéine qui a la séquence d'aminoacides de SEQ ID NO : 2 montrée dans le listage de séquences, ou</claim-text>
<claim-text>(B) une protéine qui a une séquence d'aminoacides de SEQ ID NO : 2 montrée dans le listage de séquences incluant une substitution, délétion, insertion, addition ou inversion d'au plus 10 aminoacides, et a une activité dihydrodipicolinate synthase.</claim-text><!-- EPO <DP n="44"> --></claim-text></claim>
<claim id="c-fr-01-0006" num="0006">
<claim-text>ADN qui code une protéine définie en (A) ou (B) suivant :
<claim-text>(A) une protéine qui a la séquence d'aminoacides de SEQ ID NO : 2 montrée dans le listage de séquences, ou</claim-text>
<claim-text>(B) une protéine qui a une séquence d'aminoacides de SEQ ID NO : 2 montrée dans le listage de séquences incluant une substitution, délétion, insertion, addition ou inversion d'au plus 10 aminoacides, et a une activité dihydrodipicolinate synthase.</claim-text></claim-text></claim>
<claim id="c-fr-01-0007" num="0007">
<claim-text>Micro-organisme dans lequel est introduit l'ADN selon la revendication 2 sous une forme qui permet l'expression d'une protéine codée par l'ADN.</claim-text></claim>
<claim id="c-fr-01-0008" num="0008">
<claim-text>Procédé pour produire de la L-lysine qui comprend la culture du micro-organisme selon la revendication 7 dans un milieu pour produire et accumuler de la L-lysine dans le milieu, et la collecte de la L-lysine à partir du milieu.</claim-text></claim>
</claims>
</ep-patent-document>
